bioSyntagma Company
bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Founded Date:
2015-04-02
Total Funding:
1382086
Employee Number:
1-10
Technology:
['BioTech & HealthTech', 'Education, Research & SocialTech']
Last Funding Type:
Grant
Investors Number:
2
Last Funding Date:
2018-03-19
Industry:
Aging Biomarkers
Headquarters:
Phoenix, Arizona, United States
Estimated Revenue:
$1M to $10M